µ¿¿µ»ó Àç»ý : https://blog.naver.com/bksm_research/222382349776
Human IgG based monoclonal antibodies (mAbs) are the fastest-growing category of therapeutics for cancer therapy. BioVision is pleased to offer research-grade biosimilar antibodies and ELISA Kits for your research needs. These antibodies can be used as controls for preclinical lead identification and potency assays for the development of novel therapeutics; ELISA Kits can be used to identify biomarker for (non-)response and risk factors for adverse drug reactions.
BioVision develops and offers a wide variety of products including assay kits, antibodies, recombinant proteins & enzymes, and other innovative research tools for studying Apoptosis, Metabolism, Cell Proliferation, Cellular Stress,Cell Damage and Repair, Diabetes, Obesity and Metabolic Syndrome, Stem Cell Biology, Gene Regulation, Signal Transduction, etc. BioVision's products are currently being sold in more than 60 countries worldwide.
BioVisionÀÇ BioSimilar Antibodies and ELISA Kits Webinar¸¦ º¸½Ã°í
±Ã±ÝÇϽŠ»çÇ×ÀÌ ÀÖÀ¸½Ã¸é ¾Æ·¡ ºÎ°æ¿¡½º¿¥À¸·Î ¿¬¶ô Áֽñ⠹ٶø´Ï´Ù.